Patient-Derived Xenograft Models of Pancreatic Cancer

Patient-derived xenograft (PDX) models provide a predictive preclinical model for the evaluation of an agent’s efficacy prior to entering the clinic. The CrownBio pancreatic collection contains over 100 models, including models of both North American and Asian descent. More

Benefits of CrownBio’s Pancreatic Cancer PDX Models

Our pancreatic cancer patient-derived xenograft models offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, Patient derived xenografts reflect the heterogeneity and diversity of the human patient population. PDX will give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. CrownBio’s HuPrime® Pancreatic cancer PDX model collection is well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL NUMBER CANCER SUBTYPE # per page
PA0226 AdenocarcinomaCLICK TO VIEW
PA0372 ADCCLICK TO VIEW
PA0527 ADCCLICK TO VIEW
PA0573 NACLICK TO VIEW
PA0692 ADCCLICK TO VIEW
PA0787 ADCCLICK TO VIEW
PA0968 ADCCLICK TO VIEW
PA1168 Ductal adenocarcinomaCLICK TO VIEW
PA1170 Ductal adenocarcinomaCLICK TO VIEW
PA1178 Ductal adenocarcinomaCLICK TO VIEW
PA1189 Ductal adenocarcinomaCLICK TO VIEW
PA1194 Ductal adenocarcinomaCLICK TO VIEW
PA1198 Ductal adenocarcinomaCLICK TO VIEW
PA1214 ADCCLICK TO VIEW
PA1221 Ductal adenocarcinomaCLICK TO VIEW
PA1222 Ductal adenocarcinomaCLICK TO VIEW
PA1226 Ductal adenocarcinomaCLICK TO VIEW
PA1229 ADCCLICK TO VIEW
PA1233 Ductal adenocarcinomaCLICK TO VIEW
PA1252 Ductal adenocarcinomaCLICK TO VIEW